These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1470301)

  • 21. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
    Griebel G; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice.
    Nic Dhonnchadha BA; Hascoët M; Jolliet P; Bourin M
    Behav Brain Res; 2003 Dec; 147(1-2):175-84. PubMed ID: 14659583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The modified Geller-Seifter test in rats was insensitive to GABAB receptor positive modulation or blockade, or 5-HT1A receptor activation.
    Paterson NE; Hanania T
    Behav Brain Res; 2010 Mar; 208(1):258-64. PubMed ID: 20006648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonergic involvement in conflict behaviour.
    Söderpalm B; Engel JA
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):7-13. PubMed ID: 2136217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Pharmacol Biochem Behav; 1997 Aug; 57(4):817-27. PubMed ID: 9259011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression.
    Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
    Behav Pharmacol; 2004 Dec; 15(8):523-34. PubMed ID: 15577451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects.
    Strauss CV; Vicente MA; Zangrossi H
    Behav Brain Res; 2013 Jun; 246():103-10. PubMed ID: 23499701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of 5-HT1A receptors in the anxiolytic action of S 14671 in the pigeon conflict test.
    Schreiber R; Brocco M; de Ladonchamps BL; Millan MJ
    Pharmacol Biochem Behav; 1995; 51(2-3):211-5. PubMed ID: 7667330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anxiolytic-like effects of 5-hydroxytryptamine3 (5-HT3) receptor antagonists.
    Filip M; Baran L; Siwanowicz J; Chojnacka-Wójcik E; Przegaliński E
    Pol J Pharmacol Pharm; 1992; 44(3):261-9. PubMed ID: 1470564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADN-1184, a monoaminergic ligand with 5-HT6/7 receptor antagonist action, exhibits activity in animal models of anxiety.
    Partyka A; Wasik A; Jastrzębska-Więsek M; Mierzejewski P; Bieńkowski P; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):593-602. PubMed ID: 26979176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.
    de Mello Cruz AP; Pinheiro G; Alves SH; Ferreira G; Mendes M; Faria L; Macedo CE; Motta V; Landeira-Fernandez J
    Psychopharmacology (Berl); 2005 Nov; 182(3):345-54. PubMed ID: 16133141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central serotonergic system and mechanism of anxiolytic action.
    Plaznik A; Stefański R; Jessa M; Nazar M; Bidziński A
    Acta Physiol Hung; 1996; 84(4):449-51. PubMed ID: 9328628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
    Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E
    J Pharm Pharmacol; 2005 Feb; 57(2):253-7. PubMed ID: 15720791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated.
    Kennett GA; Trail B; Bright F
    Neuropharmacology; 1998 Dec; 37(12):1603-10. PubMed ID: 9886683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
    Costall B; Naylor RJ
    Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
    Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
    Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.